ClinicalTrials.govpublic full text
Effect of Glucagon-like Peptide-1 (GLP-1) Receptor Agonist Stimulation on Smoking Consumption in Type 2 Diabetes Patients
diabetes mellitus, type 2, nicotine dependence, cigarettes, clinical pharmacology, functional magnetic resonance imaging, smoking cessation, glp-1 receptor agonist, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 993809
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.